NE-3107 Alzheimer's, Parkinson's data boost Biovie
By A Mystery Man Writer
Description
Opto Biosystems develops sensors for monitoring brain activity
Alzheimer's disease
Clinical BioWorld
Triolex - Drug Targets, Indications, Patents - Synapse
$27M brightens treatment resistant depression outlook
Eisai co. ltd.
BioVie Announces Efficacy Data from Phase 3 Trial of
In Parkinson's, adding NE3107 to levodopa aids motor, non-motor benefits
Neurastasis' non-invasive neurostimulator to improve stroke outcome
Biostage Inc.
TGR-63 BioWorld
BioVie achieves revised enrolment target in Alzheimer's trial
BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock
from
per adult (price varies by group size)